Skip to content

Effects of Psychedelic Drug Use on Neurocognitive Function and Psychological and Social Quality of Life Domains: An International Online Study

Franziska Stadler, Johan Saelens, Ioline D. Henter, Nathalie M. Rieser, Maximillian Greenwald, Elizabeth D. Ballard, Katrin H. Preller, Carlos A. Zarate, Christoph Kraus

medRxiv August 28, 2025 preprint DOI: 10.1101/2025.08.27.25334164 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Longitudinal
Sample size 759
Population International online adults who reported psychedelic drug use status
Keywords Neurocognitive Quality philosophy Function biology Drug Social function Applied psychology Clinical psychology Cognitive psychology Psychotherapist Cognition Social science Epistemology
Key findings Recent psychedelic use is associated with lower cognitive accuracy and more depressive symptoms, while lifetime use shows no cognitive decline but lower psychosocial quality of life.

Abstract

This international online study (N=759) examined the acute, subacute, and long-term effects of psychedelic drug use on cognitive performance and mental health. Participants completed cognitive tasks assessing working memory, selective attention, and visual/spatial perception, as well as questionnaires assessing mental health outcomes and quality of life. Based on self-reported substance use, participants were classified as non-users, lifetime users, and recent users. Recent users had significantly lower accuracy across all cognitive tasks, and lifetime users had the highest task accuracy without corresponding reaction time deficits. Lifetime use was not associated with long-term cognitive decline. Recent users reported more depressive and dissociative symptoms, whereas lifetime users reported lower scores. Lifetime users scored lower on psychological and social quality of life domains, indicating possible long-term psychosocial effects. These findings highlight the need to differentiate between the acute and long-term effects of psychedelics; lab-controlled, longitudinal studies are needed to enable safe clinical application.

Citations in the library

Explore topics